Adaptor protein (binds other signaling molecules via specific interaction domains), Other (does not fit classical categories such as receptor, enzyme, or ion channel)
01
Overview
SKAP2 (Src kinase-associated phosphoprotein 2) is an adaptor protein predominantly expressed in hematopoietic cells, including neutrophils, macrophages, and B cells. It contains three functional domains: a dimerization domain (DM) promoting self-association, a pleckstrin homology (PH) domain for lipid/membrane interactions, and an SH3 domain for binding Src family kinases and other interactors. SKAP2 regulates integrin-mediated actin cytoskeleton rearrangement and cluster formation, controlling adhesive and effector functions such as phagocytosis, reactive oxygen species (ROS) generation, and antibody-dependent cellular cytotoxicity (ADCC) in immune cells. Loss or deficiency of SKAP2 impairs these effector responses. SKAP2 is also implicated in inhibition of tumor invasiveness and modulation of signal transduction pathways relevant to cancer and inflammatory disease. While SKAP2 has no known direct drug, its role in immune signaling makes it a candidate for further therapeutic exploration.
Other names
Src kinase-associated phosphoprotein 2SKAP2PRAPRA70SAPSSCAP2SKAP-55HOMSKAP55RSKAP-HOMSKAP55 homologPyk2/RAFTK-associated proteinRetinoic acid-induced protein 70Src family-associated phosphoprotein 2Src kinase-associated phosphoprotein of 55-related proteinSrc-associated adapter protein with PH and SH3 domainsFyn-associated phosphoprotein SKAP55 homologue
02
Mechanism of action
None assigned directly; as there are no approved drugs specifically targeting SKAP2, assigned mechanisms are theoretical and would relate to interruption/modulation of adaptor-mediated immune signaling.
03
Biological functions
Regulation of actin polymerizationSignal transduction (integrin-mediated)Immune response activationCell adhesionCytoskeletal rearrangementPhagocytosisReactive oxygen species (ROS) productionAntibody-dependent cellular cytotoxicity (ADCC)
04
Disease associations
Cancer (implicated in tumor invasiveness and immune cell cytotoxicity)Inflammation (modulates neutrophil and macrophage effector responses)Infection (role in neutrophil killing of bacteria and fungi, associated with oral candidiasis)Potential relevance in neurodegenerative disease via regulation of alpha-synuclein phosphorylation
05
Safety considerations
Potential for immune suppression or dysregulation if broadly inhibited, due to SKAP2’s role in neutrophil and macrophage effector functionsPossible off-target cytoskeletal or adhesion effectsNo specific safety data, as no direct SKAP2 inhibitor is in clinical use.
06
Interacting drugs
None identified directly; no well-established small molecule drugs or biologics are known to specifically target SKAP2. Therapeutic modulation would likely be indirect, for example via upstream or downstream effectors (such as integrins, Syk, Fyn, or Pyk2/RAFTK).
07
Biomarkers
None established for clinical use; SKAP2 has potential as a biomarker of immune cell activation and neutrophil/macrophage function in cancer and inflammatory disease, but not currently used clinically.
Beyond the preview
Go deeper on Src kinase-associated phosphoprotein 2 (SKAP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Src kinase-associated phosphoprotein 2 (SKAP2).